EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Factors associated with death in patients admitted with Ebola virus disease to Ebola Treatment Units in Guinea, Sierra Leone, and Liberia – December 2013 to March 2016

Trokon Omarley Yeabah iD, Ibrahima Kaba, Gomathi Ramaswamy, Prabin Dahal, Alexandre Delamou, Benjamin T Vonhm, Ralph W Jetoh, Laura Merson iD, Adam C Levine, Pryanka Relan iD, Anthony D Harries iD, Ajay M V Kumar

F1000Research · 2025

DOI: 10.12688/f1000research.149612.2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift F1000Research, 2025. Verfasst von Trokon Omarley Yeabah und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Technical Services, National Public Health Institute of Liberia, Monrovia, Montserrado, 1000, Liberia. Hauptthemen laut MEDLINE: Hemorrhagic Fever, Ebola. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: World Health Organization, Special Programme for Research and Training in Tropical Diseases (TDR), Geneva, Switzerland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The 2013-2016 West African Ebola Virus Disease (EVD) outbreak resulted in 28,600 cases and 11,300 deaths officially reported to the World Health Organization. Previous studies investigating factors associated with death had conflicting findings, interventions showing promising outcomes had small sample sizes, studies were often single- or dual-country based and most focused on laboratory-confirmed EVD and not on clinically-suspected EVD. We used the Ebola data platform of the Infectious Disease Data Observatory (IDDO) to review individual patient records to assess factors associated with death, and particularly whether there were differences between laboratory-confirmed and clinically-suspected cases.

Methods

This was a cohort study involving analysis of secondary data in the IDDO database. The study population included all patients classified as having either clinically-suspected or laboratory-confirmed EVD, admitted to 22 Ebola Treatment Units (ETU) in Guinea, Liberia and Sierra Leone between December 2013 and March 2016. Baseline characteristics and treatments were documented along with ETU exit outcomes. Factors associated with death were investigated by multivariable modified Poisson regression.

Results

There were 14,163 patients, of whom 6,208 (43.8%) were laboratory-confirmed and 7,955 (56.2%) were clinically-suspected. Outcomes were not recorded in 2,889 (20.4%) patients. Of the 11,274 patients with known outcomes, 4,090 (36.3%) died: 2,956 (43.6%) with laboratory-confirmed EVD and 1,134 (18.8%) with clinically-suspected EVD. The strongest risk factor for death was confirmed disease status. Patients with laboratory-confirmed disease had 2.9 times higher risk of death compared to clinically-suspected patients, after adjusting for other co-variables. Other factors significantly associated with death included a higher risk for patients aged ≥60 years and a lower risk for patients in Sierra Leone.

Conclusions

Although laboratory-confirmed patients admitted to ETUs fared worse than clinically-suspected patients, the latter still had a substantial risk of death and more attention needs to be paid to this group in future EVD outbreaks.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hemorrhagic Fever, EbolaHumansSierra LeoneGuineaLiberiaMaleFemaleAdultMiddle AgedEbolavirusAdolescentYoung AdultRisk FactorsCohort StudiesDisease OutbreaksChildChild, Preschool

Stichwörter der Autor:innen

EbolaSORT ITWest Africafilovirusmortalityoperational researchpandemic preparednessviral haemorrhagic fever

Autor:innen und Institutionen

  • Department of Technical Services, National Public Health Institute of Liberia, Monrovia, Montserrado, 1000, Liberia.
  • African Center of Excellence for the Prevention and Control of Transmissible Diseases, University Gamal Abdel Nasser, Conakry, Guinea, 1017, Guinea.
  • All India Institute of Medical Sciences, Bibinagar, Hyderabad, 508126, India.
  • Infectious Diseases Data Observatory, Centre for Tropical Medicine & Global Health, University of Oxford, Headington, Oxfordshire, OX3 7LG, UK.
  • Centre national de formation et de recherche en santé rurale de Maferinyah, University Gamal Abdel Nasser, Forécariah, Conakry, 1017, Guinea.
  • ISARIC, Pandemic Sciences Institute, University of Oxford, Old Road Campus, Headington, Oxfordshire, OX3 7LG, UK.

ORCID-Profile: Trokon Omarley Yeabah, Laura Merson, Pryanka Relan, Anthony D Harries

Förderung

  • World Health Organization
  • Special Programme for Research and Training in Tropical Diseases (TDR), Geneva, Switzerland

Zitieren

APA

Yeabah, T. O., Kaba, I., Ramaswamy, G., Dahal, P., Delamou, A., Vonhm, B. T., Jetoh, R. W., Merson, L., Levine, A. C., Relan, P., Harries, A. D., & Kumar, A. M. V. (2025). Factors associated with death in patients admitted with Ebola virus disease to Ebola Treatment Units in Guinea, Sierra Leone, and Liberia – December 2013 to March 2016. F1000Research. https://doi.org/10.12688/f1000research.149612.2

Vancouver

Yeabah TO, Kaba I, Ramaswamy G, Dahal P, Delamou A, Vonhm BT, et al. Factors associated with death in patients admitted with Ebola virus disease to Ebola Treatment Units in Guinea, Sierra Leone, and Liberia – December 2013 to March 2016. F1000Research. 2025. doi:10.12688/f1000research.149612.2

BibTeX
@article{Yeabah2025,
  author = {Yeabah, Trokon Omarley and Kaba, Ibrahima and Ramaswamy, Gomathi and Dahal, Prabin and Delamou, Alexandre and Vonhm, Benjamin T and Jetoh, Ralph W and Merson, Laura and Levine, Adam C and Relan, Pryanka and Harries, Anthony D and Kumar, Ajay M V},
  title = {Factors associated with death in patients admitted with Ebola virus disease to Ebola Treatment Units in Guinea, Sierra Leone, and Liberia – December 2013 to March 2016},
  journal = {F1000Research},
  year = {2025},
  doi = {10.12688/f1000research.149612.2}
}
Kostenlos starten →